{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:35:40Z","timestamp":1788878140941,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Talaromyces marneffei<\/jats:italic>\n                      (\n                      <jats:italic>T. marneffei<\/jats:italic>\n                      ) is an opportunistic pathogen that infects immunodeficient children. The aim of the study is to determine the clinical features and peripheral immune state of\n                      <jats:italic>Talaromyces marneffei (T. marneffei)<\/jats:italic>\n                      infections in children for early detection and diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively reviewed 21 pediatric patients who were diagnosed with\n                      <jats:italic>T. marneffei<\/jats:italic>\n                      infections and were followed up in the Guangzhou Women and Children\u2019s Medical Center from January 2010 to January 2020. For each patient, we collected and analyzed clinical characteristics, peripheral immunological results, genetic tests, complications and prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Common clinical features of the patients included fever (20\/21, 95.24%), cough (17\/21, 80.95%) and hepatomegaly (17\/21, 80.95%). Severe complications included septic shock (12\/21, 57.14%), hemophagocytic lymphohistiocytosis (HLH) (11\/21, 52.38%), acute respiratory distress syndrome (ARDS) (10\/21, 47.62%), multiple organ dysfunction syndrome (MODS) (9\/21, 42.86%), and disseminated intravascular coagulation (DIC) (7\/21, 33.33%). Eleven children (11\/21, 52.38%) eventually died of\n                      <jats:italic>T. marneffei<\/jats:italic>\n                      infections. All patients were HIV negative. Seven cases revealed reduced antibody levels, especially IgG. Higher levels of IgE were detected in 9 cases with an obvious increase in two patients. Ten patients showed decreased complement C3 levels, some of whom had low C4 levels. Three patients displayed decreased absolute T lymphocyte counts, including the CD 4+ and CD 8+ subsets. A reduction in NK cells was present in most patients. No patient had positive nitro blue tetrazolium (NBT) test results. Nine patients were screened for common genetic mutations. Of the cases, one case had no disease-specific gene mutation. Four children had confirmed hyperimmunoglobulin M syndrome (HIGM) with\n                      <jats:italic>CD40LG<\/jats:italic>\n                      variation, one case had severe combined immunodeficiency (SCID), and one case had hyper-IgE syndrome (HIES). One patient was identified as having a heterozygous mutation in\n                      <jats:italic>STAT3<\/jats:italic>\n                      gene; however, he showed no typical clinical manifestations of HIES at his age. One patient had a mutated\n                      <jats:italic>COPA<\/jats:italic>\n                      gene with uncertain pathogenic potential. Another patient was diagnosed with HIES that depended on her clinical features and the National Institutes of Health (NIH) scoring system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>T. marneffei<\/jats:italic>\n                      infections in HIV-negative children induced severe systemic complications and poor prognosis. Children with\n                      <jats:italic>T. marneffei<\/jats:italic>\n                      infections commonly exhibited abnormal immunoglobulin levels in peripheral blood, particularly decreased IgG or increased IgE levels, further suggesting possible underlying PIDs in these patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-05978-z","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T15:02:31Z","timestamp":1616252551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases"],"prefix":"10.1186","volume":"21","author":[{"given":"Qiang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingkang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genquan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"issue":"3","key":"5978_CR1","first-page":"418","volume":"49","author":"M Capponi","year":"1956","unstructured":"Capponi M, Segretain G, Sureau P. Penicillosis from Rhizomys sinensis. Bull Soc Pathol Exot Filiales. 1956;49(3):418\u201321.","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"1","key":"5978_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","volume":"19","author":"N Vanittanakom","year":"2006","unstructured":"Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95\u2013110.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"5978_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11046-019-00410-2","volume":"184","author":"C Cao","year":"2019","unstructured":"Cao C, Xi L, Chaturvedi V. Talaromycosis (penicilliosis) due to talaromyces (penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia. 2019;184(6):709\u201320.","journal-title":"Mycopathologia"},{"issue":"11","key":"5978_CR4","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1473-3099(17)30303-1","volume":"17","author":"AH Limper","year":"2017","unstructured":"Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV\/AIDS. Lancet Infect Dis. 2017;17(11):e334\u201343.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5978_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/clinids\/14.4.871","volume":"14","author":"K Supparatpinyo","year":"1992","unstructured":"Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14(4):871\u20134.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5978_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11046-019-00373-4","volume":"184","author":"J Guo","year":"2019","unstructured":"Guo J, Li BK, Li TM, Wei FL, Fu YJ, Zheng YQ, Pan KS, Huang CY, Cao CW. Characteristics and prognosis of talaromyces marneffei infection in non-HIV-infected children in southern China. Mycopathologia. 2019;184(6):735\u201345.","journal-title":"Mycopathologia"},{"issue":"2","key":"5978_CR7","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1093\/cid\/cir754","volume":"54","author":"PP Lee","year":"2012","unstructured":"Lee PP, Chan KW, Lee TL, Ho MH, Chen XY, Li CH, Chu KM, Zeng HS, Lau YL. Penicilliosis in children without HIV infection--are they immunodeficient? Clin Infect Dis. 2012;54(2):e8\u2013e19.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5978_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/ped.2016.0722","volume":"30","author":"H Fan","year":"2017","unstructured":"Fan H, Huang L, Jin Y, Chen C, Lu G, Zhang D, Jiang W. Study of Penicillium marneffei infection in pediatric patients without human immunodeficiency virus infection in china. Pediatr Allergy Immunol Pulmonol. 2017;30(1):53\u20139.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"8","key":"5978_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Holland SM, Klein C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency. J Clin Immunol. 2015;35(8):696\u2013726. https:\/\/doi.org\/10.1007\/s10875-015-0201-1.","journal-title":"J Clin Immunol"},{"issue":"3","key":"5978_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1086\/302547","volume":"65","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Schaffer AA, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65(3):735\u201344.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"5978_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424\u2013432 e428.","journal-title":"J Allergy Clin Immunol"},{"issue":"1\u20132","key":"5978_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11046-012-9577-0","volume":"175","author":"Y Hu","year":"2013","unstructured":"Hu Y, Zhang J, Li X, Yang Y, Zhang Y, Ma J, Xi L. Penicillium marneffei infection: an emerging disease in mainland China. Mycopathologia. 2013;175(1\u20132):57\u201367.","journal-title":"Mycopathologia"},{"issue":"34","key":"5978_CR13","doi-asserted-by":"publisher","first-page":"e1439","DOI":"10.1097\/MD.0000000000001439","volume":"94","author":"W Zeng","year":"2015","unstructured":"Zeng W, Qiu Y, Lu D, Zhang J, Zhong X, Liu G. A Retrospective analysis of 7 human immunodeficiency virus-negative infants infected by Penicillium marneffei. Medicine. 2015;94(34):e1439.","journal-title":"Medicine"},{"issue":"4","key":"5978_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/jinf.2002.1062","volume":"45","author":"KH Ranjana","year":"2002","unstructured":"Ranjana KH, Priyokumar K, Singh TJ, Gupta Ch C, Sharmila L, Singh PN, Chakrabarti A. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002;45(4):268\u201371.","journal-title":"J Infect"},{"issue":"12","key":"5978_CR15","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1128\/JCM.39.12.4535-4540.2001","volume":"39","author":"SS Wong","year":"2001","unstructured":"Wong SS, Wong KH, Hui WT, Lee SS, Lo JY, Cao L, Yuen KY. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol. 2001;39(12):4535\u201340.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"5978_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/BOR.0000000000000633","volume":"31","author":"P Conigliaro","year":"2019","unstructured":"Conigliaro P, Triggianese P, Ballanti E, Perricone C, Perricone R, Chimenti MS. Complement, infection, and autoimmunity. Curr Opin Rheumatol. 2019;31(5):532\u201341.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"5978_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc.2015.5","volume":"16","author":"MG Morvan","year":"2016","unstructured":"Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016;16(1):7\u201319.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5978_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11046-018-0255-8","volume":"184","author":"XJ Han","year":"2019","unstructured":"Han XJ, Su DH, Yi JY, Zou YW, Shi YL. A literature review of blood-disseminated P. marneffei infection and a case study of this infection in an HIV-negative child with comorbid eosinophilia. Mycopathologia. 2019;184(1):129\u201339.","journal-title":"Mycopathologia"},{"issue":"14","key":"5978_CR19","doi-asserted-by":"publisher","first-page":"e0215","DOI":"10.1097\/MD.0000000000010215","volume":"97","author":"H Fan","year":"2018","unstructured":"Fan H, Huang L, Yang D, Lin Y, Lu G, Xie Y, Yu J, Zhang D. Pediatric hyperimmunoglobulin E syndrome: a case series of 4 children in China. Medicine. 2018;97(14):e0215.","journal-title":"Medicine"},{"issue":"4","key":"5978_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","volume":"36","author":"TJ Vece","year":"2016","unstructured":"Vece TJ, Watkin LB, Nicholas S, Canter D, Braun MC, Guillerman RP, Eldin KW, Bertolet G, McKinley S, de Guzman M, et al. Copa syndrome: a novel autosomal dominant immune dysregulatory disease. J Clin Immunol. 2016;36(4):377\u201387.","journal-title":"J Clin Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05978-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-05978-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05978-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T15:03:16Z","timestamp":1616252596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-05978-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5978"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-05978-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-128043\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"14 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Guangzhou Women and Children\u2019s Medical Center of Guangzhou Medical University. Written informed consents were signed during hospitalization. The data used in this study was anonymised before its use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}